PluroGen Therapeutics, LLC, Announces Issuance Of US Patent To Fight Biofilm In Wounds

NORRISTOWN, Pa. - July 20, 2016 - PRLog -- PluroGen Therapeutics, LLC, a biotech company that provides clinically advanced topical products for chronic (non-healing) wounds and burns, today announced that the United States Patent and Trademark Office has issued US Patent #9,283,278 covering the company's PluroGel® Micelle Matrix Biomaterial to fight biofilm in wounds.

This new biofilm patent strengthens PluroGen's intellectual property portfolio of 9 current patents and 10 additional patent applications. The biofilm patent confirms the Company's strategic commitment in developing solutions for complex wounds that are useful for patients, doctors and healthcare providers.

"We are confident that PluroGen's extensive patent estate will continue to provide our company with long-term protection for our strategic focus in the burn and wound care market," said Neal Koller, President and CEO of PluroGen. "This additional patent for fighting biofilm, thought to be one of the key reasons that nonhealing wounds do not heal, represents another significant milestone in securing comprehensive protection for the PluroGel Micelle Matrix line of products."

Nonhealing wounds are responsible for a significant economic burden and an increase in morbidity and mortality for patients. Rates of clinical wound closure remain unacceptably low. One suspected reason for nonhealing wound closure is the presence of biofilm. Biofilm is a thin, slimy film of bacteria that adheres to a surface and is thought to physically block a wound from closing. A key characteristic of PluroGel is its bio-physical function of breaking up or preventing biofilm formation, which in turn can aid in wound closure.

PluroGel is a unique, biocompatible, cell-friendly, surfactant-based biomaterial and is beneficial in all phases of wound healing and for all tissue types. Developed at the world-renowned University of Virginia, PluroGel Products give doctors, nurses, patients and consumers advantaged and cost effective new tools for skin, burn and wound care.